TABLE 1

FROM:

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

S R Bramhall, J Schulz, J Nemunaitis, P D Brown, M Baillet and J A C Buckels

Table 1. Patient demographic data by treatment group